Nuclear targeting by the growth factor midkine. - Wikidata - awgldk - TriplyDB

Nuclear targeting by the growth factor midkine.

Nuclear targeting by the growth factor midkine.

http://www.wikidata.org/entity/Q34286252

about

Internalization of cationic peptides: the road less (or more?) traveled Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes Pancreatic cancer Structure and function of midkine as the basis of its pharmacological effects Structure-function analysis of full-length midkine reveals novel residues important for heparin binding and zebrafish embryogenesis Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.Nuclear translocation of urokinase-type plasminogen activator Transcriptome profiling of the tubular porcine conceptus identifies the differential regulation of growth and developmentally associated genes.Construction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines.Structure-function analysis of nucleolin and ErbB receptors interactions.DNA damage-induced translocation of S100A11 into the nucleus regulates cell proliferation Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization.The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.Synthesis and investigation of a radioiodinated F3 peptide analog as a SPECT tumor imaging radioligand Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type Pigment epithelium-derived factor (PEDF) interacts with transportin SR2, and active nuclear import is facilitated by a novel nuclear localization motif.Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability.Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1 A novel post-translational modification of nucleolin, SUMOylation at Lys-294, mediates arsenite-induced cell death by regulating gadd45α mRNA stability.New light on a long-known protein family.Midkine: a promising molecule for drug development to treat diseases of the central nervous system Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin.Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model.Interactions of lactoferrin with cells involved in immune function.Antagonizing midkine accelerates fracture healing in mice by enhanced bone formation in the fracture callus Midkine promotes selective expansion of the nephrogenic mesenchyme during kidney organogenesis Midkine translocated to nucleoli and involved in carcinogenesis.Midkine secretion protects Hep3B cells from cadmium induced cellular damage.Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer Midkine: a novel prognostic biomarker for cancer.Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32.Therapeutic potential of midkine in cardiovascular disease.Lactoferrin, a key molecule in immune and inflammatory processes.Midkine in the pathology of cancer, neural disease, and inflammation.

P2860

Q24655939-8C6CB80C-793C-4E0F-A80C-FDE8FEB65740 Q24656678-9CAAC028-F175-4B5E-B7CE-9A2779122CB6 Q24672113-45C527D6-18A3-47F2-BE80-4FEBF17393EF Q27005724-D53F973C-230C-4DB4-A624-907BC5D6E0AE Q27013798-F032FCDD-5A72-40DB-9D86-3D65E8DDACE1 Q27684027-4931A234-3922-41A5-A8E7-60A0A431C8FE Q28472975-8E9E4320-E180-4716-ABC5-BA02DB110A61 Q30446159-3B8DCEE5-1FCE-455A-BD99-2A416833DE33 Q30482426-2ACCBA68-D23A-4D7A-BE0E-954108ABDBF5 Q33253603-EB907076-977D-411F-87A9-37F1469BA83D Q33266700-D2463A49-F35F-4294-8545-837D4C58E00E Q33478425-21A1F11B-DE08-4DAC-A668-085E01F48C2B Q33774606-976976CB-4F3E-436C-8E59-59AD1C9D5183 Q33784401-51F64327-2F59-430C-A682-E668052F0A63 Q33915644-0E603748-AE03-4672-90AD-DA0E29352D5A Q33979930-1EBAFDCF-A316-4DEB-8C3B-1C2BC3B4422B Q33980633-E0F0D9E2-AD94-4DA1-9959-8BC2BCB6D16E Q34058474-00D8D5D7-F4AE-488C-BC17-E8DD5A46D2C6 Q34443186-F95C133E-E99A-4A80-AE1E-E45F64198A0B Q34624412-1CAEFCEF-F158-40D0-BA12-66B06FA98E1F Q35103925-603A935C-7BE9-4A97-9902-F556E329BBD7 Q35581908-48752ACA-D866-419F-ACD9-6238D1C2C798 Q35701268-032C1B70-7CF7-4EA8-88E3-46C3709CDD80 Q35785556-E4DD743C-656A-4F49-BB10-2E0DD2C5C3DB Q36048718-B1CF39E2-33CB-42F9-B6E0-F8ABEE516E0A Q36160231-A68A4E7D-DC42-44D1-9E6E-82714261232E Q36324866-90ACF28E-357E-4340-905B-8E10F32BC84C Q36394982-94E76D81-3296-42A0-A8B2-D3C8B76A90DF Q36561693-3533B40C-4DCF-4D29-8579-796B2AA18BF5 Q36579317-D06EA2F5-9EFD-469B-B892-91951612AEF0 Q37034753-64614F18-8362-456B-9F8E-AE8CEC84D1C0 Q37079364-B4F0E35B-F377-4962-86B2-094420CDD311 Q37122317-070642FB-589D-4E1C-9E8D-4C3D45C4ECAD Q37169731-B2D89D86-9CF9-4C7F-A1D4-4D2B0CE9905D Q37277677-556062CC-AD08-4698-8CAD-89B8B7843039 Q37328317-C328A82D-814C-4480-99E9-7C966855C836 Q37393805-5820A20D-B779-43A5-93F8-FAC48BD3CE24 Q37585406-AE19831D-9C44-4D83-8298-C97B3A083E51 Q37964040-E614E52D-0FE1-4298-829A-F005827C2A71 Q38020971-420E294F-6AA1-4FE5-B0BD-15D8AE3068DB

P2860

Nuclear targeting by the growth factor midkine.

http://www.wikidata.org/entity/Q34286252

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Nuclear targeting by the growth factor midkine.

@ast

Nuclear targeting by the growth factor midkine.

@en

Nuclear targeting by the growth factor midkine.

@nl

type

label

Nuclear targeting by the growth factor midkine.

@ast

Nuclear targeting by the growth factor midkine.

@en

Nuclear targeting by the growth factor midkine.

@nl

prefLabel

Nuclear targeting by the growth factor midkine.

@ast

Nuclear targeting by the growth factor midkine.

@en

Nuclear targeting by the growth factor midkine.

@nl

P1433

Q34286252-E252FD0F-CFA6-4D37-B0EE-8ABE23FB9E29

P1476

Q34286252-90AA6110-F0B7-4480-BA50-F4B898354DB6

P2093

Q34286252-2CE98E5C-D710-43B4-A9A8-0FCE7CFDE177

Q34286252-38DFF138-53E6-4E76-B5BA-C7AFBF73A4E2

Q34286252-3A9EF61A-2C36-4592-A509-FBC1A6646497

Q34286252-41673377-48F7-49DF-9F60-A4FC8A450F4C

Q34286252-7AD7B2D9-93DB-4017-8352-DC6775AB1A4A

Q34286252-8CB76335-417C-41D7-9092-819208944020

Q34286252-A8670EC4-D61B-4E34-888F-AD2D1B9FE426

Q34286252-C36256BD-5B73-49BE-B812-8DAA1398341A

Q34286252-DF462FB4-C995-4AAE-B7E7-33CC5692055F

P2860

Q34286252-01810993-C45E-4EFB-AB5D-DAD5A0BC591E

Q34286252-04E76EC6-E491-46C4-9F7E-C1B0C3256862

Q34286252-0554CDE4-EC53-44DA-94C1-96AAEBDA5D99

Q34286252-07675424-EE4F-4F80-8271-1B458A92FEAE

Q34286252-10674D34-50F9-4721-BC5D-09420C8E7509

Q34286252-12766BEA-E9AE-4534-8BF9-7FE277723DAD

Q34286252-14554D2F-E553-4617-86D1-193DF13EF036

Q34286252-15A89A32-7A80-4640-81BF-18BC71FE4EDC

Q34286252-18FD2DF8-9FFD-4C31-A784-7E7ABD8B5063

Q34286252-19F4B90F-54D0-4854-913D-FE9462B21286

P304

Q34286252-48CB4E1D-CFDA-4054-A980-6332912D68A1

P31

Q34286252-CBF1AB20-5D24-4133-8F1F-C874F118F2D0

P356

Q34286252-9C53D802-4068-4335-8AC4-6377F55786CD

P407

Q34286252-1798191C-F7D5-435E-A9A3-BFAB6FC4416B

P433

Q34286252-7934D12C-51DB-41C9-8CF7-63A5F324A700

P478

Q34286252-8A79DA50-64CA-44A2-85BB-3765150BF011

P577

Q34286252-2D8B9162-FF97-46E2-99E8-4A10ED0C41F5

P5875

Q34286252-BFE4EE9B-9D14-4B83-9F90-CC632F908D34

P698

Q34286252-E28B2BBB-0E4E-4213-AD3B-122CDD2C80FF

P932

Q34286252-882AFB2B-A4AB-43E5-B761-31A734B0BB36

P356

MCB.22.19.6788-6796.2002

P1433

Molecular and Cellular Biology

P1476

Nuclear targeting by the growth factor midkine.

@en

P2093

Guojun Bu

http://www.w3.org/2001/XMLSchema#string

Hidehiko Saito

http://www.w3.org/2001/XMLSchema#string

Kenji Kadomatsu

http://www.w3.org/2001/XMLSchema#string

Lynn M McCormick

http://www.w3.org/2001/XMLSchema#string

Makoto Hirai

http://www.w3.org/2001/XMLSchema#string

Takashi Muramatsu

http://www.w3.org/2001/XMLSchema#string

Tatsuya Inui

http://www.w3.org/2001/XMLSchema#string

Terutoshi Kimura

http://www.w3.org/2001/XMLSchema#string

Yoshihisa Shibata

http://www.w3.org/2001/XMLSchema#string

P2860

Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2

Reelin is a ligand for lipoprotein receptors

Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation

Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction

LDL-receptor-related proteins in Wnt signal transduction

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

Role for nucleolin/Nsr1 in the cellular localization of topoisomerase I.

Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway

LDL receptor-related protein as a component of the midkine receptor

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

P304

6788-6796

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MCB.22.19.6788-6796.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11172779

http://www.w3.org/2001/XMLSchema#string

P698

12215536

http://www.w3.org/2001/XMLSchema#string

P932

134045

http://www.w3.org/2001/XMLSchema#string